ClinConnect ClinConnect Logo
Search / Trial NCT05105113

Evaluation of Survival and Success Rates of Zirzonia Dental Implants

Launched by RAMBAM HEALTH CARE CAMPUS · Oct 25, 2021

Trial Information

Current as of June 27, 2025

Unknown status

Keywords

ClinConnect Summary

This clinical trial is studying the success and survival rates of Zirconia dental implants compared to traditional Titanium implants. Zirconia implants are a newer type of dental implant made from a ceramic material that may offer benefits in appearance and comfort. The trial is currently recruiting participants aged 18 and older who need a dental implant to replace a missing tooth, as long as their dental situation does not require extensive surgery beforehand.

To be eligible for the trial, participants must be in good health, not pregnant or breastfeeding, and should not have certain conditions like uncontrolled diabetes or active gum disease. Those who join the study will have the chance to receive a Zirconia dental implant and will be monitored to see how well it works over time. This research aims to help improve dental implant options for everyone, so participating could contribute to important advancements in dental care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subject must have voluntarily signed the informed consent form.
  • Male or female patient aged ≥18 Years old.
  • Replacing a missing tooth by use of implant supported restoration in implantation sites that do not require extensive augmentation procedure.
  • Good primary implant stability at implant placement (35N and more).
  • Compliance with study schedules and arrival at study visits.
  • Exclusion Criteria:
  • Pregnant or lactating women.
  • Imbalance diabetes.
  • Head and neck rediation therapy.
  • Active Periodontal disease and caries.
  • Patient in need of tooth extraction and immediat implantation.

About Rambam Health Care Campus

Rambam Health Care Campus is a leading medical institution located in Haifa, Israel, renowned for its comprehensive patient care, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, Rambam is dedicated to advancing healthcare through innovative research and development, facilitating a wide range of clinical studies across various therapeutic areas. The campus boasts state-of-the-art facilities, a multidisciplinary team of expert researchers and clinicians, and a robust infrastructure that supports rigorous scientific inquiry and ethical standards in clinical trials. By fostering collaboration and leveraging cutting-edge technology, Rambam Health Care Campus aims to enhance treatment options and improve patient outcomes globally.

Locations

Haifa, , Israel

Patients applied

AH

MD

PS

VJ

KC

JR

PM

LG

CA

+3
13 patients applied

Trial Officials

Hadar Zigdon, DMD

Principal Investigator

Rambam Health Care Campus

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials